BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28859974)

  • 21. Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel
    Erdős M; Jakobicz E; Soltész B; Tóth B; Bata-Csörgő Z; Maródi L
    Front Immunol; 2020; 11():967. PubMed ID: 32547544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Report: Disseminated
    Chen K; Tan J; Qian S; Wu S; Chen Q
    Front Immunol; 2021; 12():682350. PubMed ID: 34421897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutually exclusive STAT1 modifications identified by Ubc9/substrate dimerization-dependent SUMOylation.
    Zimnik S; Gaestel M; Niedenthal R
    Nucleic Acids Res; 2009 Mar; 37(4):e30. PubMed ID: 19174562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hes-1 SUMOylation by protein inhibitor of activated STAT1 enhances the suppressing effect of Hes-1 on GADD45α expression to increase cell survival.
    Chiou HY; Liu SY; Lin CH; Lee EH
    J Biomed Sci; 2014 Jun; 21(1):53. PubMed ID: 24894488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
    Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
    J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF-κB response genes in T cells.
    Sarkar K; Sadhukhan S; Han SS; Vyas YM
    Blood; 2015 Oct; 126(14):1670-82. PubMed ID: 26261240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PML positively regulates interferon gamma signaling.
    El Bougrini J; Dianoux L; Chelbi-Alix MK
    Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
    Zheng J; van de Veerdonk FL; Crossland KL; Smeekens SP; Chan CM; Al Shehri T; Abinun M; Gennery AR; Mann J; Lendrem DW; Netea MG; Rowan AD; Lilic D
    Eur J Immunol; 2015 Oct; 45(10):2834-46. PubMed ID: 26255980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO).
    Droescher M; Begitt A; Marg A; Zacharias M; Vinkemeier U
    J Biol Chem; 2011 May; 286(21):18731-46. PubMed ID: 21460228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.
    Rogers RS; Horvath CM; Matunis MJ
    J Biol Chem; 2003 Aug; 278(32):30091-7. PubMed ID: 12764129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis.
    Eslami N; Tavakol M; Mesdaghi M; Gharegozlou M; Casanova JL; Puel A; Okada S; Arshi S; Bemanian MH; Fallahpour M; Molatefi R; Seif F; Zoghi S; Rezaei N; Nabavi M
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):191-201. PubMed ID: 28597685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchiectasis and Recurrent Respiratory Infections with a
    Huh HJ; Jhun BW; Choi SR; Kim YJ; Yun SA; Nham E; Kong T; Ki CS; Koh WJ
    Yonsei Med J; 2018 Oct; 59(8):1004-1007. PubMed ID: 30187709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant.
    Blanco Lobo P; Lei WT; Pelham SJ; Guisado Hernández P; Villaoslada I; de Felipe B; Lucena JM; Casanova JL; Olbrich P; Puel A; Neth O
    Pediatr Allergy Immunol; 2021 Nov; 32(8):1804-1812. PubMed ID: 34289170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.
    Tripathi V; Chatterjee KS; Das R
    J Biol Chem; 2019 Oct; 294(40):14546-14561. PubMed ID: 31371453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SUMO modification of NZFP mediates transcriptional repression through TBP binding.
    Kim M; Chen Z; Shim MS; Lee MS; Kim JE; Kwon YE; Yoo TJ; Kim JY; Bang JY; Carlson BA; Seol JH; Hatfield DL; Lee BJ
    Mol Cells; 2013 Jan; 35(1):70-8. PubMed ID: 23269432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA625 inhibits STAT1-mediated transactivation potential in esophageal cancer cells.
    Guo-Wei H; Chun-Quan L; Lian-Di L; Ji-Wei J; Lin L; Ji-Yu D; Jin-Cheng G; En-Min L; Li-Yan X
    Int J Biochem Cell Biol; 2019 Dec; 117():105626. PubMed ID: 31605752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chinese Pedigree of Chronic Mucocutaneous Candidiasis Due to STAT1 Gain-of-Function Mutation: A Case Study and Literature Review.
    Wang X; Zhao W; Chen F; Zhou P; Yan Z
    Mycopathologia; 2023 Apr; 188(1-2):87-97. PubMed ID: 36335528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Candida infection, bronchiectasis, immunoglobulin abnormalities, and stunting: a case report of a natural mutation of STAT1 (c.986C>G) in an adolescent male.
    Yu Y; Xu F; Shen H; Wu J
    BMC Infect Dis; 2021 Jan; 21(1):38. PubMed ID: 33413180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.
    Uzel G; Sampaio EP; Lawrence MG; Hsu AP; Hackett M; Dorsey MJ; Noel RJ; Verbsky JW; Freeman AF; Janssen E; Bonilla FA; Pechacek J; Chandrasekaran P; Browne SK; Agharahimi A; Gharib AM; Mannurita SC; Yim JJ; Gambineri E; Torgerson T; Tran DQ; Milner JD; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1611-23. PubMed ID: 23534974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.